Illumina signed up for a new collaboration with AstraZeneca with the goal of aligning their artificial intelligence development efforts in a way that combines genomic analysis and drug discovery re | The project will explore whether applying AI to DNA and other omics sequencing data can increase their returns in successful biological targets and promising drug candidates.
